G. Gargano

发表

Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

V. Adamo, S. Corsale, V. Agnese, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Analytical and clinical evaluation of a new tumor marker in breast cancer: CA 27.29

G. Serio, A. Paradiso, G. Gargano, 1992, The International journal of biological markers.

Combined carboplatin plus ifosfamide and cisplatin in patients with advanced ovarian carcinoma. A phase I-II study. GOCS (Gynecological Oncology Cooperative Study).

G. Gargano, V. Lorusso, M. de Lena, 1998, Gynecologic oncology.

Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum.

M. Guida, G. Gargano, V. Lorusso, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of tumour markers in ovarian cancer.

G. Gargano, V. Lorusso, M. de Lena, 1990, Clinical and experimental obstetrics & gynecology.

A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer

A. Russo, S. Corsale, V. Agnese, 2006, Breast Cancer Research and Treatment.

Carboplatin plus ifosfamide as salvage treatment of epithelial ovarian cancer: a pilot study.

A. Paradiso, G. Gargano, V. Lorusso, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serum TAG 72 levels in different human carcinomas.

M. Garrubba, G. Gargano, M. Correale, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

S. Corsale, V. Agnese, F. Fulfaro, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

S. Corsale, V. Agnese, S. Cascio, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

pS2—A new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer

A. Paradiso, F. Schittulli, G. Gargano, 2009, Cell Biophysics.

Tumor necrosis factor and soluble interleukin-2 receptor: two immunological biomarkers in female neoplasms.

G. Gargano, M. Correale, I. Abbate, 1992, European journal of gynaecological oncology.

TP53 and p16INK4A, but not H‐KI‐Ras, are involved in tumorigenesis and progression of pleomorphic adenomas

A. Russo, S. Corsale, V. Agnese, 2006, Journal of cellular physiology.

BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses

A. Giordano, A. Russo, S. Corsale, 2007, Breast Cancer Research and Treatment.

Behaviour of Four Serum Tumor Markers in Pregnant Women

G. Gargano, M. Correale, I. Abbate, 1993, The International journal of biological markers.

NR1H3 (LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma

A. López-Guillermo, E. Campo, S. Pileri, 2022, Hematological oncology.

Infiltrating cribriform carcinoma of the breast. A clinico-pathologic and immunohistochemical study of 5 cases.

F. Schittulli, G. Gargano, F. Zito, 1996, European journal of gynaecological oncology.

A New Ensemble Method for Detecting Anomalies in Gene Expression Matrices

Gian Maria Zaccaria, Flavia Esposito, Nicoletta Del Buono, 2021, Mathematics.

Ovarian fibroma: our experience of 34 cases.

F. Schittulli, G. Gargano, M. de Lena, 2003, European journal of gynaecological oncology.

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study.

M. Guida, G. Gargano, V. Lorusso, 2001, European journal of cancer.

Ovarian bilateral cystic teratomas: diagnosis and therapy in a young woman.

G. Gargano, V. Lorusso, M. de Lena, 1990, Clinical and experimental obstetrics & gynecology.

Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

V. Adamo, S. Corsale, V. Agnese, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.